The penetration of supersaturated solutions of piroxicam across silicone membranes and human skin in vitro

Journal of Controlled Release

Volumn 46, Issue 3, 1997, Pages 205-214

  Pellett, M A ^a   Castellano, S ^b   Hadgraft, J ^a   Davis, A F ^c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Donor phase temperature; Human skin; Piroxicam; Silicone membrane; Supersaturation

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE; PIROXICAM;

ARTICLE; ARTIFICIAL MEMBRANE; CONTROLLED STUDY; CRYSTALLIZATION; DIFFUSION; DIFFUSION COEFFICIENT; DRUG DOSE; DRUG SOLUBILITY; DRUG STABILITY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MEMBRANE TRANSPORT; NORMAL HUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; SKIN; SKIN PENETRATION; SOLUTION AND SOLUBILITY;

EID: 0030899727     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01595-7     Document Type: Article

References (35)

1. J.N. Twist and J.L. Zatz, Influence of solvents on paraben permeation through idealized skin model membranes. J. Soc. Cosmet. Chem. 37 (1986) 429-444.
2. T. Higuchi, Physical chemical analysis of percutaneous absorption process from creams and ointments. J. Soc. Cosmet. Chem. 11 (1960) 85-97.
3. E.V. Khamskii, Crystallisation from Solutions, Consultants Bureau, New York, 1969.
4. T. Henmi, M. Fujii, K. Kikuchi, N. Yamanobe and M. Matsumoto, Application of an oily gel formed by hydrogenated soybean phospholipids as a percutaneous absorption-type ointment base. Chem. Pharm. Bull. 42 (1994) 651-655.
5. S. Kondo and I. Sugimoto, Enhancement of transdermal delivery by superfluous thermodynamic potential. I. Thermodynamic analysis of nifedipine transport across the lipoidal barrier. J. Pharmacobio-Dyn. 10 (1987) 587-594.
6. C.M. Chiang, G.L. Flynn, N.D. Weiner, W.J. Addicks and G.J. Szpunar, Bioavailability assessment of topical delivery systems: In vitro delivery of minoxidil from prototypical semi-solid formulations. Int. J. Pharm. 49 (1989) 109-114.
7. C.G.T. Mathias, R.H. Guy, R.S. Hinz and H.I. Maibach, Percutaneous penetration enhancement of solvent-deposited solids by the volatile solvent. J. Invest. Dermatol. 84 (1985) 360.
8. S. Tanaka, Y. Takashima, H. Murayama and S. Tsuchiya, Studies on drug release from ointments. V. Release of hydrocortisone butyrate propionate from topical dosage forms to silicone rubber. Int. J. Pharm. 27 (1985) 29-38.
9. F. Theeuwes, R.M. Gale and R.W. Baker, Transference: a comprehensive parameter governing permeation of solutes through membranes. J. Membr. Sci. 1 (1976) 3-16.
10. A. Davis and J. Hadgraft, Effect of supersaturation on membrane transport: 1. Hydrocortisone acetate. Int. J. Pharm. 76 (1991) 1-8.
11. N.A. Megrab, A.C. Williams and B.W. Barry, Oestradiol permeation through human skin and silastic membrane: effects of propylene glycol and supersaturation. J. Control. Release 36 (1995) 277-294.
12. M.A. Pellett, A.F. Davis and J. Hadgraft, Effect of supersaturation on membrane transport: 2. Piroxicam. Int. J. Pharm. 111 (1994) 1-6.
13. M.A. Pellett, J. Davis, J. Hadgraft and K.R. Brain, The stability of supersaturated solutions for topical drug delivery. in: Proceedings of the 3rd International Prediction of Percutaneous Penetration Conference, La Grande Motte, France, 1993, pp. 292-298.
14. J.W. Mullin, Crystallization. Butterworths, London, 1961.
15. R.H. Guy and J. Hadgraft, The estimation of skin permeation parameters, in: Proceedings of the 4th UKaps Annual Conference, Nottingham, 1995, p. 58.
16. A.C. Watkinson, K.R. Brain and K.A. Walters, The penetration of ibuprofen through human skin in vitro: vehicle, enhancer and pH effects. in: Proceedings of the 3rd International Prediction of Percutaneous Penetration Conference, La Grande Motte, France, 1993, pp. 335-341.
17. J.A. Cordero, E. Escribano, A.C. Calpena, L.M. Alarcon, R. Obach and J. Domenech, Transdermal penetration of a series of NSAIDs. in: Proceedings of the 21st International Symposium on Controlled Release of Bioactive Materials, Nice, France, 1994, pp. 449-450.
18. M.N. Femi-Oyewo and M.S. Spring, Studies on paracetamol crystals produced by growth in aqueous solutions. Int. J. Pharm. 112 (1994) 17-28.
19. A. Hasegawa, R. Kawamura, H. Nakagawa and I. Sugimoto, Physical properties of solid dispersions of poorly water-soluble drugs with enteric coating agents. Chem. Pharm. Bull. 33 (1985) 3429-3435.
20. G.A. Holder and J. Thorne, Inhibition of crystallisation by polymers. Polymer Preprints Am. Chem. Soc. Div. Poly. Chem. 20 (1979) 766-769.
21. A.P. Simonelli, S.C. Mehta and W.I. Higuchi, Inhibition of sulfathiazole crystal growth. J. Pharm. Sci. 59 (1970) 633-638.
22. H. Sekikawa, M. Nakano and T. Arita, Inhibitory effect of polyvinylpyrrolidone on the crystallization of drugs. Chem. Pharm. Bull. 26 (1978) 118-126.
23. O.I. Corrigan and R.F. Timoney, The influence of polyvinylpyrrolidone on the dissolution properties of hydroflumethazide. J. Pharm. Pharmacol. 27 (1975) 759-764.
24. A.R. Ebian, M.A. Moustafa, S.A. Khalil and M.M. Motawi, Succinylsulfathiazole crystal forms II: effects of additives on kinetics of interconversion. J. Pharm. Sci. 64 (1975) 1481-1484.
25. S. Miyazaki, M. Nakano and T. Arita, Effect of additives on the polymorphic transformation of chlortetracycline hydrochloride crystals. Chem. Pharm. Bull. 24 (1976) 2094-2101.
26. A.F. Davis and J. Hadgraft, Supersaturated solutions as topical drug delivery systems. in: K.A. Walters and J. Hadgraft (Eds.) Pharmaceutical Skin Penetration Enhancement, Marcel Dekker, New York, 1993, pp. 243-267.
27. O.I. Corrigan and R.F. Timoney, Anomalous behaviour of some hydroflumethazide crystal samples. J. Pharm. Pharmacol. 26 (1974) 838-840.
28. S. Khoshkhoo and J. Anwar, Crystallization of polymorphs: Effects of supersaturation and solvent. J. Pharm. Pharmacol. 43 (1991) 36.
29. J.H. De Smidt, J.G. Fokkens, H. Grijseels and D.J.A. Crommelin, Dissolution of theophylline monohydrate and anhydrous theophylline in buffer solutions. J. Pharm. Sci. 75 (1986) 497-501.
30. E. Shefter and T. Higuchi, Dissolution behaviour of crystalline solvated and non-solvated forms of some pharmaceuticals. J. Pharm. Sci. 52 (1963) 781-791.
31. A. Abd El-Bary, M.A.A. Kassem, N. Foda, T.S. and S.S. Badawi, Controlled crystallization of chlorpropamide from surfactant and polymer solutions. Drug Dev. Ind. Pharm. 16 (1990) 1649-1660.
32. K. Uekama, K. Ikegami, Z. Wang, Y. Horiuchi and F. Hirayama, Inhibitory effect of 2-hydroxypropyl-B-cyclodextrin on crystal growth of nifedipine during storage: superior dissolution and oral bioavailability compared with polyvinylpyrrolidone k-30. J. Pharm. Pharmacol. 44 (1992) 73-78.
33. K. Uekama, K. Oh, T. Irie, M. Otagiri, Y. Nishimiya and T. Nara, Stabilization of isosorbide 5-mononitrate in solid state by B-cyclodextrin complexation. Int. J. Pharm. 25 (1985) 339-346.
34. J.J. Torres-Labandeira, P. Davignon and J. Pitha, Oversaturated solutions of drug in hydroxypropylcyclodextrins: Parenteral preparation of pancratistatin. J. Pharm. Sci. 80 (1990) 384-386.
35. The Merck Index, 11th ed., Merck and Co., Inc., USA, 1989.